LIANBIO's ticker is and the CUSIP is 53000N108. A total of 40 filers reported holding LIANBIO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,491 | -34.7% | 1,001 | 0.0% | 0.00% | – |
| Q2 2023 | $2,282 | +16.3% | 1,001 | 0.0% | 0.00% | – |
| Q1 2023 | $1,962 | +19.5% | 1,001 | 0.0% | 0.00% | – |
| Q4 2022 | $1,642 | -98.5% | 1,001 | -98.2% | 0.00% | – |
| Q3 2022 | $110,000 | +5400.0% | 55,146 | +5409.1% | 0.00% | – |
| Q2 2022 | $2,000 | -86.7% | 1,001 | -75.1% | 0.00% | – |
| Q1 2022 | $15,000 | – | 4,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,282,084 | $4,929,000 | 4.16% |
| Perceptive Advisors | 56,560,211 | $122,170,000 | 3.83% |
| SCHF (GPE), LLC | 937,500 | $2,025,000 | 2.99% |
| VR Adviser, LLC | 5,378,341 | $11,617,000 | 2.29% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,314,173 | $7,159,000 | 0.52% |
| Affinity Asset Advisors, LLC | 450,000 | $972,000 | 0.41% |
| Altium Capital Management LP | 315,191 | $681,000 | 0.27% |
| RA Capital Management | 4,622,574 | $9,985,000 | 0.27% |
| 22NW, LP | 141,223 | $305,000 | 0.16% |
| Logos Global Management LP | 394,486 | $852,000 | 0.16% |